A new study offers hope for earlier detection for fatty liver disease. This new blood test claims to predict it 16 years ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Researchers in South Korea have developed an organoid disease model and non-destructive stiffness analysis technology for ...

Multi-modal data integration of single-nuclei RNA and ATAC sequencing with spatial transcriptomics, provides new molecular insights into gene regulatory networks driving cell state transitions in ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, critical role in dampening ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

On this World Liver Day, the message is clear: protecting your liver begins with a closer look at your plate—and your glass.

As the field of proteomics continues to advance, scientists are using new methods to answer longstanding questions about rare ...